We continue to view OrganiGram Holdings Inc (OTCMKTS:OGRMF) as having a basic claim to next-level respect in the evolution of the cannabis patch as a competitive market segment given its spot in the pecking order, its growth rate, its move to start climbing the ladder as far as strategic investments, and its expanding geographic diversification.
The chart shows a stock clearly finding a recent bid at key technical support, with last week’s tape offering up an excellent example. Wednesday, in particular, highlights the key signals, as the stock dipped below its 200-day simple moving average only to close higher. That support was reaffirmed on Thursday and Friday, suggesting an important bid chasing up under the stock during this recent pullback.
OrganiGram Holdings Inc (OTCMKTS:OGRMF) casts itself as a company that produces and sells medical marijuana to individuals and physicians in Canada. It offers marijuana plants, seeds, and cuttings; cannabis oil; and dried flower and cannabis.
The company sells its products through phone and online store. It also operates healing centers that offer treatments for post-traumatic stress disorders, chronic pain, and trauma therapy. In addition, the company exports its products.
OrganiGram Holdings Inc. was founded in 2013 and is based in Moncton, Canada.
Moreover, OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition-specific medical marijuana for patients in Canada.
OGRMF’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations.
According to company materials, “From the day we started back in 2013, it’s been about making lives better – for our clients, our people, and our community. We’re based in Moncton, New Brunswick, the heart of the Maritimes, but at OrganiGram Holdings we’re committed to improving the quality of life for Canadians across the country. For us, this means working with health-care providers and industry organizations, supporting research and education, and providing a safe, effective product. To be effective in that last goal, we made a decision to produce organic cannabis. Growing certified organic medical cannabis isn’t easy, in fact, most licensed producers won’t take this on. It means more care, more testing, more rules… but in the end, it means a product that we feel delivers on our goals in the best way. And improving the quality of life for Canadians is not just about getting safe, quality product to them effectively. It’s about creating jobs, being good neighbors and contributing to our community.”
Find out when $OGRMF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, OGRMF just demonstrated an important level of technical support at a key level. That signals to us that the stock is very much worth watching at present. Traders will note a -4% decline during the past week. Moreover, the name has witnessed a pop in interest, as transaction volume levels have recently pushed 47% over what the stock has registered over the longer term. However, as discussed above, that includes a very strong show of support at the key rising 200-day MA.
Part of this may be its recent move to expand on the strategic side into the EU, but it also may have to do with its course of expansion in North America, including its recent supply agreement with the Province of British Columbia.
“Organigram’s strategic vision has always been to establish a definitive national footprint,” says Greg Engel, Organigram’s Chief Executive Officer. “We are proud to realize that vision and offer Canadians from coast to coast access to our growing recreational product portfolio.”
Now commanding a market cap of $569.17M, OGRMF has a significant war chest ($155.8M) of cash on the books, which compares with about $9.1M in total current liabilities. OGRMF is pulling in trailing 12-month revenues of $12.2M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 94.3%. This is an exciting story, and we look forward to a follow-up chapter as events transpire. Sign-up for continuing coverage on shares of $OGRMF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $OGRMF, either long or short, and we have not been compensated for this article.